Logo image of BHAC

FOCUS IMPACT BH3 ACQUISITION (BHAC) Stock Fundamental Analysis

NASDAQ:BHAC - Nasdaq - US22677T1025 - Common Stock - Currency: USD

10.55  0 (0%)

Fundamental Rating

1

Taking everything into account, BHAC scores 1 out of 10 in our fundamental rating. BHAC was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of BHAC have multiple concerns. BHAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BHAC had positive earnings in the past year.
In the past year BHAC has reported a negative cash flow from operations.
BHAC Yearly Net Income VS EBIT VS OCF VS FCFBHAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M -10M

1.2 Ratios

Industry RankSector Rank
ROA 5.61%
ROE 7.71%
ROIC N/A
ROA(3y)13.57%
ROA(5y)N/A
ROE(3y)16.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHAC Yearly ROA, ROE, ROICBHAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 10 20 30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BHAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BHAC Yearly Profit, Operating, Gross MarginsBHAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, BHAC has less shares outstanding
Compared to 1 year ago, BHAC has an improved debt to assets ratio.
BHAC Yearly Shares OutstandingBHAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
BHAC Yearly Total Debt VS Total AssetsBHAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 5.05 indicates that BHAC is not in any danger for bankruptcy at the moment.
BHAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 5.05
ROIC/WACCN/A
WACCN/A
BHAC Yearly LT Debt VS Equity VS FCFBHAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.08 indicates that BHAC may have some problems paying its short term obligations.
BHAC has a Quick Ratio of 0.08. This is a bad value and indicates that BHAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
BHAC Yearly Current Assets VS Current LiabilitesBHAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BHAC have decreased strongly by -42.91% in the last year.
EPS 1Y (TTM)-42.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-181.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 55.53, which means the current valuation is very expensive for BHAC.
BHAC is valuated expensively when we compare the Price/Earnings ratio to 27.41, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 55.53
Fwd PE N/A
BHAC Price Earnings VS Forward Price EarningsBHAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHAC Per share dataBHAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BHAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FOCUS IMPACT BH3 ACQUISITION

NASDAQ:BHAC (10/9/2024, 8:00:00 PM)

10.55

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners18.66%
Inst Owner Change0%
Ins Owners61.46%
Ins Owner Change-200.69%
Market Cap73.32M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 55.53
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.93
P/tB 3.93
EV/EBITDA N/A
EPS(TTM)0.19
EY1.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0
BVpS2.69
TBVpS2.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.61%
ROE 7.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)13.57%
ROA(5y)N/A
ROE(3y)16.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z 5.05
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-181.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-193.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.15%
OCF growth 3YN/A
OCF growth 5YN/A